University of Crete (UOC)
Ο ρόλος της αναιμίας και της αντιμετώπισης της σε ασθενείς με ιδιοπαθείς φλεγμονώδεις νόσους του εντέρου
Abstract
dc:descriptionBackground: Anemia is the most common extraintestinal manifestation of Inflammatory Bowel Disease (IBD) that affects negatively the patients' quality of life. The differentiation of anemia types, particularly between iron deficiency anemia (IDA) and anemia of chronic disease (ACD), remains a major diagnostic challenge among patients with IBD given the fact that these patients have increased inflammation burden and the commonly used marker is Ferritin (Fer). Aim and Methods: The aim of this study was to determine the frequency and real-life management of anemia in IBD patients in Greece and to evaluate the diagnostic performance of various iron laboratory parameters, with specific focus on serum hemojuvelin (sHjv) as a potential biomarker of anemia in IBD. The first part of the study was conducted at 17 Greek IBD referral centers and the second part at the Gastroenterology Department of the University Hospital of Heraklion. Demographic, clinical, laboratory, IBD and anemia treatment data were collected and analyzed retrospectively for 1394 IBD patients. In the second part, sera from 152 consecutive IBD patients of the outpatient IBD clinic in University Hospital of Heraklion were collected. On top of the demographics and clinical information, transferrin saturation (Tsat), soluble transferrin receptor (sTFR), sTFR index and hepcidin (Hpc), were assessed. In addition, sHjv levels were measured using a commercially available Elisa kit. Results: In the first part of the study 1394 IBD patients [560 ulcerative colitis (UC), 834 Crohn's disease (CD)] were enrolled. Anemia at any time was reported in 687 (49.3%) patients of whom 413 (29.6%) had episodic and 274 (19.7%) had recurrent/persistent anemia. Anemia was diagnosed before IBD in 45 (6.5%), along with IBD in 269 (39.2%) and after IBD in 373 (54.3%) patients. In the multivariate analysis the presence of extraintestinal manifestations (p = 0.0008), IBD duration (p = 0.026), IBD related surgeries and hospitalizations (p = 0.026 and p = 0.004 accordingly) were risk factors of recurrent/persistent anemia. Serum ferritin was measured in 839 (60.2%) IBD patients. Among anemic patients, 535 (77.9%) received treatment. Iron supplementation was administered in 485 (90.6%) patients, oral in 142 (29.3%) and intravenous in 393 (81%). In the second part of the study 152 IBD patients were included, 89 (58.6%) had a history of anemia, whereas 40 (26.3%) were anemic at the study entry. The majority of the anemic patients (57.5%) had IDA. ROC Analysis demonstrated that sTFR >1.64 mg/l (AUC 0.774) and sTFR index >1.06 (AUC 0.921) were significant predictors for IDA diagnosis (both p<0.001). Neither Hpc nor sHjv showed diagnostic utility for non-IDA anemia [cut-offs >31317 pg/ml (AUC=0.511, p=0.9107) and <=227.04 ng/ml (AUC 0.612 p=0.219), respectively]. Serum Hjv levels were negatively correlated with Hpc in all patients (–0.25) and in non-anemic patients (-0.29), both p<0.05. IBD patients with history of anemia had significantly increased cumulative incidence of IBD surgery 15.8% versus 4.8%, 21.5% versus 4.8% and 21.5% versus 11.8%, respectively in 10, 20 and 30 years of follow up (p=0.047), median follow-up time 15 years (IQR 8.12-24.04). In the multivariate analysis, risk of surgery was only related to non-inflammation CD phenotype (p=0.0039) and to total exposure in more than 3 advanced treatment agents (immunomodulators/biologics) (p=0.0441). Conclusions: The frequency of anemia in IBD patients is approximately 50%. Recurrent/persistent anemia may be observed in 20% of cases and is independently associated with the presence of extraintestinal manifestations, IBD duration, IBD related surgeries and hospitalizations. Anemia treatment is administered in up to 78% of the anemic IBD patients with the majority of them receiving iron intravenously. sTFR and particularly sTFR index are valuable diagnostic tools for identifying true IDA, whereas Hpc and sHjv appears to have no diagnostic role for ACD. sHjv shows a consistent negative correlation with Hpc. The presence of anemia in IBD patients was correlated with increased risk of IBD surgery during follow-up. Nevertheless, independent risk factors of IBD related surgery were the non-inflammatory CD phenotype and the total exposure to above 3 advanced IBD treatment agents.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Foteinogiannopoulou, Kalliopi
- Φωτεινογιαννοπούλου, Καλλιόπη
Subjects
dc:subject × 14- Αναιμία
- Σιδηροπενική αναιμία
- Αναιμία χρόνιας νόσου
- Ιδιοπαθείς φλεγμονώδεις εντερικές νόσοι
- Anemia
- Iron deficiency anemia
- Anemia of chronic disease
- Inflammatory bowel diseases (IBD)
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γαστροεντερολογία
- Clinical Medicine
- Medical and Health Sciences
- Gastroenterology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61977